Urgent colonoscopy is not necessary in case of colonic diverticular bleeding without extravasation on contrast-enhanced computed tomography

IF 1.1 4区 医学 Q4 GASTROENTEROLOGY & HEPATOLOGY Arab Journal of Gastroenterology Pub Date : 2024-02-01 DOI:10.1016/j.ajg.2023.11.003
Tomoya Sugiyama , Yuki Kojima , Yoshikazu Hirata , Masahide Ebi , Takashi Yoshimine , Kazunori Adachi , Yoshiharu Yamaguchi , Shinya Izawa , Yasutaka Hijikata , Yasushi Funaki , Naotaka Ogasawara , Makoto Sasaki , Wataru Ohashi , Satoshi Sobue , Kunio Kasugai
{"title":"Urgent colonoscopy is not necessary in case of colonic diverticular bleeding without extravasation on contrast-enhanced computed tomography","authors":"Tomoya Sugiyama ,&nbsp;Yuki Kojima ,&nbsp;Yoshikazu Hirata ,&nbsp;Masahide Ebi ,&nbsp;Takashi Yoshimine ,&nbsp;Kazunori Adachi ,&nbsp;Yoshiharu Yamaguchi ,&nbsp;Shinya Izawa ,&nbsp;Yasutaka Hijikata ,&nbsp;Yasushi Funaki ,&nbsp;Naotaka Ogasawara ,&nbsp;Makoto Sasaki ,&nbsp;Wataru Ohashi ,&nbsp;Satoshi Sobue ,&nbsp;Kunio Kasugai","doi":"10.1016/j.ajg.2023.11.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and aims</h3><p>Acute lower gastrointestinal bleeding (ALGIB) increase with age and the administration of antiplatelet drugs. Colonic diverticular bleeding (CDB) is the most common cause of ALGIB, and endoscopic hemostasis is an effective treatment for massive CDB. But in patients without extravasation on contrast-enhanced computed tomography (CECT), the efficacy of urgent colonoscopy (UCS) is controversial from the point of the clinical course, including rebleeding rate. We aimed to establish a potential strategy including UCS for CDB patients without extravasation on CECT.</p></div><div><h3>Patients and methods</h3><p>Patients from two centers treated for CDB without extravasation on CECT between July 2014 and July 2019 were retrospectively identified (n = 282). Seventy-four underwent UCS, and 208 received conservative management. We conducted two analyses. The first analysis investigates the risk factors of rebleeding rate within 5 days after administration (very early rebleeding), and no UCS (NUCS) was not the independent factor of the very early rebleeding. The second analysis is whether UCS positively influenced the clinical course after hospitalization.</p></div><div><h3>Results</h3><p>The prevalence of very early rebleeding and early rebleeding (6–30 days from admission), patients requiring blood transfusion within 0–5 days and 6–30 days post-admission, and duration of hospitalization were examined as clinical course factors between UCS and NUCS group. There was no significant difference between the UCS and non-UCS groups in the clinical course factors. UCS for the CDB patients without extravasation was not improved rebleeding rate and clinical course.</p></div><div><h3>Conclusions</h3><p>UCS is not necessary in case of<!--> <!-->CDB patient without extravasation on CECT.</p></div>","PeriodicalId":48674,"journal":{"name":"Arab Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1687197923000916/pdfft?md5=5e4b55ffe2679cb2cdae69c29797168b&pid=1-s2.0-S1687197923000916-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arab Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1687197923000916","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims

Acute lower gastrointestinal bleeding (ALGIB) increase with age and the administration of antiplatelet drugs. Colonic diverticular bleeding (CDB) is the most common cause of ALGIB, and endoscopic hemostasis is an effective treatment for massive CDB. But in patients without extravasation on contrast-enhanced computed tomography (CECT), the efficacy of urgent colonoscopy (UCS) is controversial from the point of the clinical course, including rebleeding rate. We aimed to establish a potential strategy including UCS for CDB patients without extravasation on CECT.

Patients and methods

Patients from two centers treated for CDB without extravasation on CECT between July 2014 and July 2019 were retrospectively identified (n = 282). Seventy-four underwent UCS, and 208 received conservative management. We conducted two analyses. The first analysis investigates the risk factors of rebleeding rate within 5 days after administration (very early rebleeding), and no UCS (NUCS) was not the independent factor of the very early rebleeding. The second analysis is whether UCS positively influenced the clinical course after hospitalization.

Results

The prevalence of very early rebleeding and early rebleeding (6–30 days from admission), patients requiring blood transfusion within 0–5 days and 6–30 days post-admission, and duration of hospitalization were examined as clinical course factors between UCS and NUCS group. There was no significant difference between the UCS and non-UCS groups in the clinical course factors. UCS for the CDB patients without extravasation was not improved rebleeding rate and clinical course.

Conclusions

UCS is not necessary in case of CDB patient without extravasation on CECT.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在结肠憩室出血没有外渗的情况下,紧急结肠镜检查是不必要的。
背景和目的:急性下消化道出血(ALGIB)随着年龄和抗血小板药物的使用而增加。结肠憩室出血(CDB)是ALGIB最常见的病因,内镜下止血是治疗大量CDB的有效方法。但在对比增强计算机断层扫描(CECT)上没有外渗的患者中,从临床病程(包括再出血率)的角度来看,紧急结肠镜检查(UCS)的疗效存在争议。我们的目的是建立一个潜在的策略,包括UCS的CDB患者没有CECT外渗。患者和方法:回顾性分析2014年7月至2019年7月期间,来自两个中心的CDB未发生CECT外渗的患者(n = 282)。74例行UCS, 208例行保守治疗。我们进行了两项分析。第一个分析调查了给药后5天内再出血率(极早再出血)的危险因素,无UCS (NUCS)不是极早再出血的独立因素。第二个分析是UCS是否正向影响住院后的临床病程。结果:UCS组与NUCS组的临床病程影响因素为极早再出血、早期再出血(入院后6 ~ 30天)、入院后0 ~ 5天和6 ~ 30天需要输血的患者、住院时间。UCS组与非UCS组在临床病程因素上无显著差异。无外渗的CDB患者的UCS没有改善再出血率和临床病程。结论:cdb患者CECT无外渗时,不需要UCS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Arab Journal of Gastroenterology
Arab Journal of Gastroenterology Medicine-Gastroenterology
CiteScore
2.70
自引率
0.00%
发文量
52
期刊介绍: Arab Journal of Gastroenterology (AJG) publishes different studies related to the digestive system. It aims to be the foremost scientific peer reviewed journal encompassing diverse studies related to the digestive system and its disorders, and serving the Pan-Arab and wider community working on gastrointestinal disorders.
期刊最新文献
"Mitigating tuberculosis reactivation risk in IBD patients on anti-TNF therapy". Epidemiological and anatomopathological profile of colorectal cancer in Northern Morocco between 2017 and 2019. Ginsenoside Rg3 enhances the anticancer effects of 5-fluorouracil in colorectal cancer and reduces drug resistance and the Hedgehog pathway activation. Effect of Lactobacillus acidophilus, Calcium, and Moringa oleifera leaves extract co-administration can prevent chemical-induced carcinogenesis. Current trends and research hotspots in the study of flavonoids for ulcerative colitis: A bibliometric study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1